idiopathic macular telangiectasia type 1
ORPHA: 3533441 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| bevacizumab Cold Chain | IV infusion, 25 mg/mL solution; intravitreal injection (off-label) | FDA Approved, EMA Approved | 12 | 14d |
Classification & Codes
Orphanet Code
ORPHA:353344idiopathic macular telangiectasia type 1
| Orphanet | ORPHA:353344 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO